Pharmaceutical Executive
Episodes
Repurposing Drugs - How One Doctor Saved His Own Life And Hopes To Save Others
30 Mar 2023
Contributed by Lukas
Two companies join forces to unlock the hidden potential in existing drugs to save lives suffering from rare diseases. In 2010, Dr. David Fajgenbaum, ...
Tearing Down Silos to Usher Innovative Medicines to Patients Faster
16 Mar 2023
Contributed by Lukas
Cathi Ahearn is a seasoned biotechnology leaders with formative stints at Genentech, Roche, and now at Bristol Myers Squibb, as SVP of worldwide comme...
Recruiting Talent In Pharma
02 Mar 2023
Contributed by Lukas
Across most industries, finding and keeping the right talent is a constant challenge for companies. This challenge is perhaps even more prevalent in t...
Behind the Creative: Let’s Hear from the Creators
27 Feb 2023
Contributed by Lukas
Join Tina Fascetti, CCO of The Agency Network at MJH Life Sciences for a podcast interview with Ryan Potter, ACD Art, and Priscila Ramos, ACD Copy, fr...
The Explosive Arrival of Chat GPT and Generative AI
16 Feb 2023
Contributed by Lukas
In his position, Faruk Capan leads thousands of employees around the globe with a focus on bold innovation—one can imagine how excited he is about C...
Working In A Male-Dominated Field
02 Feb 2023
Contributed by Lukas
It is no easy feat to break into a male-dominated field as a woman, no less the bio/pharmaceutical industry. Piper Trelstad, PhD, head of chemistry, m...
Let’s Get Social: The Ascendancy of Social Media to the Top of the Media Mix
19 Jan 2023
Contributed by Lukas
Amanda Powers-Han, chief marketing officer at Greater Than One, has a couple of decades in the industry and is always on top of the latest trends in ...
Gene Therapies: 2023 Predictions and Commercialization Challenges
05 Jan 2023
Contributed by Lukas
Cell and gene therapies are at the tip of everyone’s tongues in biopharma. Significant headway has been made in this space, though there is more res...
In Flux: The Sales & Marketing Outlook For 2023
22 Dec 2022
Contributed by Lukas
As a society and industry, we’re emerging out of a period of hyper-accelerated digital and virtual growth, a positive born out of the COVID-19 pande...
The Gap In Mental Health Treatments: Schizophrenia
08 Dec 2022
Contributed by Lukas
On this week’s episode, Meg Rivers, editor-in-chief, and Miranda Schmalfuhs, group social media editor, speak with Steve Paul, chairman of the board...
Tuning Into CTV - Real Time Data For Marketers
24 Nov 2022
Contributed by Lukas
Marcella Milliet Sciorra, Chief Marketing Officer at DeepIntent, discusses Connected TV, or CTV, how it differs from over the top, and how CTV fits in...
Leadership in the US vs. Europe and Launching a Rare Disease Drug
10 Nov 2022
Contributed by Lukas
In episode 121 of the Pharm Exec Podcast, Nathalie Dompé, co-CEO of Dompé Pharmaceuticals, shares a glimpse into her journey in the pharma industry,...
Sounds of Our Sister Brands
27 Oct 2022
Contributed by Lukas
In episode 120, Nico Saraceno, editor of Pharmaceutical Commerce and host of the Pharmaceutical Commerce Podcast, and Andy Studna, associate editor an...
Behind the Creative…..Inspiring Award Winning Creative with Sarah McKinnon
26 Oct 2022
Contributed by Lukas
Sarah McKinnon, Senior Art Director at The Grey Group, discusses her entrance into the advertising world through blending art and science in school, u...
Making a Difference
13 Oct 2022
Contributed by Lukas
In episode 119, Doina Ionescu, Managing Director, UK & ROI, at Merck, discusses her career journey, gender discrimination in the workplace, her ro...
Derm Decisions For Younger Children
29 Sep 2022
Contributed by Lukas
In episode 118, Paula Brown Stafford, CEO of Novan, discusses the company’s upcoming NDA filing for its topical agent for molluscum contagiosum, wha...
From Persia To Precision Medicine
15 Sep 2022
Contributed by Lukas
In episode 117, Helen Sabzevari, CEO of Precigen, discusses her drive to study science as a Persian-born woman, the opportunities she’s had to resea...
The Quest To Counter Alzheimer’s
01 Sep 2022
Contributed by Lukas
In episode 116, Dr. Greg Rippon, vice president and chief medical partner at Genentech, discusses his work in Alzheimer’s and his outlook for the fu...
Defining Diversity
18 Aug 2022
Contributed by Lukas
In episode 115, Raj Verma, chief diversity, culture, and experience officer at Sanofi, discusses the various ways people see diversity around the worl...
Behind the Creative….Inspiring Award Winning Creative with Halen Dang and Carrie Morris
09 Aug 2022
Contributed by Lukas
Proximyl Health’s Halen Dang, VP, Creative Director of Art and Carrie Morris, VP, Creative Director of Copy discuss remote teamwork and how to succe...
Managing Workplace Stress
04 Aug 2022
Contributed by Lukas
In episode 114, Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, discusses why it’s important to manage high levels of workplace stress, a...
Serving The Patient
21 Jul 2022
Contributed by Lukas
In episode 113, Indranil Bagchi, senior vice president and worldwide head, value and access at Novartis, and member of Pharmaceutical Executive Editor...
Behind the Creative…Inspiring Award Winning Creative Carolyn O’Neill
19 Jul 2022
Contributed by Lukas
Carolyn O’Neill, Chief Creative Officer of Centron discusses their APEX-award winning global disease awareness campaign for both HCPs and patients, ...
Emerging Successful
07 Jul 2022
Contributed by Lukas
Nima Farzan, CEO of Kinnate, who was one of Pharmaceutical Executive’s Emerging Pharma Leaders in 2013, discusses how he’s successfully navigated ...
Behind the Creative…Inspiring Award Winning Creative with Omair Ahmed
29 Jun 2022
Contributed by Lukas
Nexus Pharmaceuticals' Chief Strategy Officer Omair Ahmed discusses their APEX-award winning EMERPHED™ campaign, which built on the ideas of simplif...
Creating A Space For Women’s Health
23 Jun 2022
Contributed by Lukas
Kevin Ali, CEO of Organon, talks about how’s he’s lead the launch of a new niche company for women’s health, and what he hopes it can achieve.
Inside The Metaverse For Pharma
09 Jun 2022
Contributed by Lukas
Ken Winell, chief technology officer of Greater Than One, talks about the metaverse and the potential it has to serve the pharma industry.
Behind the Creative…Inspiring Award Winning Creative with John England
08 Jun 2022
Contributed by Lukas
CDM Princeton’s Senior Creative Vice President John England discuss the company’s APEX-award winning Ilumya campaign “Defy the Laws of Psoriasis...
New Guidance For Biopharma Investor ESG Communications
26 May 2022
Contributed by Lukas
Myrto Kontaxi, a partner in the Biopharma Sustainability Roundtable, and lead author on its updated Biopharma Investor ESG Communications Guidance; an...
Behind the Creative...Inspiring Award Winning Creative with Cindy Machles and Nate Whipple
25 May 2022
Contributed by Lukas
Glue Advertising's Cindy Machles, CEO and Co-founder & Nate Whipple, Producer, discuss their APEX-award winning respiratory campaign "For My Lung ...
Announcing Our 2022 Emerging Pharma Leaders
12 May 2022
Contributed by Lukas
In episode 108, the rest of the PharmExec editorial staff join Elaine and Miranda to give more insight into the profiles they've written about the ele...
Behind the Creative...Inspiring Award Winning Creative with Troy Clark and Anne Brown
11 May 2022
Contributed by Lukas
Biolumina's Troy Clark, SVP, Creative Director, and Anne Brown, SVP, Creative Director, Copy discuss their APEX-award winning website "Be in the Know"...
The Pulse Of Oncology
28 Apr 2022
Contributed by Lukas
In episode 107, Camille Hertzka, VP, head of oncology US medical at AstraZeneca, talks about her experience as a leader in oncology over the years and...
Changing Cancer Care with CAR-T
14 Apr 2022
Contributed by Lukas
In episode 106, Christi Shaw, CEO of Kite, a Gilead Company, talks about how CAR T-cell therapies are impacting cancer care and the lessons she’s le...
A Look at Latin America
31 Mar 2022
Contributed by Lukas
In episode 105, Rolf Hoenger, area head of Latin America at Roche Pharma, talks about the current pharma landscape in Latin America and his expe...
The Art of Science
17 Mar 2022
Contributed by Lukas
In episode 104, Susanne Schaffert, president of Novartis Oncology, discusses her career journey, which has combined both a passion for the arts and sc...
Respiratory Issues
03 Mar 2022
Contributed by Lukas
Robert Clarke, CEO and co-founder of Kinaset Therapeutics, talks about developing inhaled therapies to fight asthma and COPD, which is especially rele...
Serving an Aging Population
17 Feb 2022
Contributed by Lukas
In episode 102, Mike Devoy, chief medical officer of Bayer, also executive vice president of medical affairs and pharmacovigilance for Bayer’s Pharm...
Digital Awareness
03 Feb 2022
Contributed by Lukas
Bruno Larvol, CEO and founder of Larvol, discusses how he is invested in the digital world, both personally and professionally, and the impact it can ...
Industry Outlook 2022
20 Jan 2022
Contributed by Lukas
Our milestone 100th episode includes Lisa Henderson, group editorial director; Julian Upton, European and online editor; Fran Pollaro, senior editor; ...
Episode 99: Caring About Specialty
06 Jan 2022
Contributed by Lukas
Bill Sibold, executive vice president and head of Sanofi Genzyme, talks about his work in specialty care over the past 10 years and what makes it uniq...
Episode 98: Family Run Pharma
23 Dec 2021
Contributed by Lukas
Giacomo Chiesi, Head of Global Rare Diseases at the Chiesi Group, discusses what it has been like growing up around pharma, and how he’s turned a fa...
Episode 97: Diving Into Pharm Exec’s 2022 Pipeline Report
09 Dec 2021
Contributed by Lukas
Mike Ward, Global Head of Thought Leadership in the Decision Resources Group at Clarivate, discusses PharmExec’s 2022 pipeline report, which appears...
Episode 96: Forging New Paths In Oncology
25 Nov 2021
Contributed by Lukas
Tim Whitten, CEO and president of Taiho Oncology, discusses how innovative thinking—from developing new therapies to creating a podcast for employee...
Episode 95: CEOs Share Their Industry Outlook
11 Nov 2021
Contributed by Lukas
Jeff Stoll, US Life Sciences Strategy Leader at KPM, talks about some of the highlights from KPMG’s recent Global Pharma CEO Outlook report.
Episode 94: Women Leading The Way
28 Oct 2021
Contributed by Lukas
Amie Krause, Senior Vice President and Chief People Officer, and Kristin Yarema, Chief Commercial Officer, of Atara Biotherapeutics, talk about gender...
Episode 93: Cultural Cues in Oncology
14 Oct 2021
Contributed by Lukas
Michael Petroutsas, Senior Vice President and Head of GSK’s US Oncology Business Unit, talks about how his background has taught him the importance ...
Episode 92: Digesting The GI Market
30 Sep 2021
Contributed by Lukas
Tom McCourt, CEO of Ironwood Pharmaceuticals, talks about his 30-plus years in the gastrointestinal space, including his experiences bringing top GI m...
Episode 91: A New Way to Partner With Academia
16 Sep 2021
Contributed by Lukas
Dr. Michael Henderson, chief business officer of BridgeBio Pharma, and one of Pharm Exec’s 2021 Emerging Pharma Leaders, discusses how his company g...
Episode 90: Innovating Ways to Fight Cancer
02 Sep 2021
Contributed by Lukas
Dr. Edith Perez, Chief Medical Officer of Bolt Biotherapeutics, discusses how she approaches drug development in oncology, and what she contributes ou...
Episode 89: Cellicon Valley Outlook
19 Aug 2021
Contributed by Lukas
Audrey Greenberg, co-founder and executive managing director of the Center for Breakthrough Medicines and Discovery Labs, discusses how cell and gene ...
Episode 88: The Science of Starting a Biotech
05 Aug 2021
Contributed by Lukas
Yan Chen, CEO of Elpis Biopharmaceuticals, discusses how she transformed her scientific background into launching her own biotech.
Episode 87: Attacking Bladder Cancer From All Sides
22 Jul 2021
Contributed by Lukas
Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.
Behind the Creative...Inspiring Award Winning Creative with Cherie Davies
16 Jul 2021
Contributed by Lukas
Cherie Davies, SVP, Executive Creative Director at FCB Chicago, talks about inspiring award-winning creative, especially in COVID times.
Episode 86: Cancer as a Catalyst
08 Jul 2021
Contributed by Lukas
Emma Chaffin, vice president and country head of Galapagos UK, talks about how she has dealt with her own cancer diagnosis and the effects it has had...
Episode 85: Managing the Dynamics of Oncology
24 Jun 2021
Contributed by Lukas
Teresa Bitetti, President of the Global Oncology Business Unit at Takeda Pharmaceuticals discusses the dynamic nature of the oncology space, and how l...
Episode 84: Vaccines Beyond COVID
10 Jun 2021
Contributed by Lukas
Judy Stewart, head of US vaccines at GSK, talks about the effects of people missing their recommended vaccinations during the pandemic and the importa...
Behind the Creative...Inspiring Award Winning Creative with Kathy Delaney
10 Jun 2021
Contributed by Lukas
Tina and Kathy Delaney, CCO of Publicis Health/Saatchi Wellness, chat about creative inspiration, trends and surreal career moments in this episode of...
Episode 83: The Strength of Veterans in Pharma
27 May 2021
Contributed by Lukas
Mike Starich, CEO of Orion Talent, and Dr. Armand Balboni, CEO of Appili Therapeutics, discuss how veterans have specific skills and qualities that ca...
Behind the Creative: Creative Impact on Brand Success
25 May 2021
Contributed by Lukas
Darrell Wakefield, Franchise Head, Solid Tumor, Sanofi Genzyme, talks creative impact on brand success.
Announcing Our 2021 Emerging Pharma Leaders
21 May 2021
Contributed by Lukas
Since 2008, Pharmaceutical Executive has recognized a class of biopharma professionals to receive the title Emerging Pharma Leader. This year, along w...
Episode 82: Integrating Sustainability Into Biopharma Strategy
13 May 2021
Contributed by Lukas
Sandor Schoichet, an independent advisor, and director of Meridian Management Consultants based in San Francisco, and Pharm Exec’s Sustainability co...
Behind the Creative: Inspiring Award-Winning Creative
03 May 2021
Contributed by Lukas
Shaheed Peera, President, Founder and CEO of The Creative Floor Awards, London, and Global Creative Lead for Reckitt Benckiser ECom, talks about inspi...
Episode 81: Cancer Research Amid COVID
29 Apr 2021
Contributed by Lukas
Dr. Michele Cleary, CEO of the Mark Foundation for Cancer Research, discusses how the foundation has navigated COVID to help keep critical cancer rese...
Episode 80: Rugby Rules in Pharma
15 Apr 2021
Contributed by Lukas
John Furey, CEO of Imvax and an Editorial Advisory Board member for Pharm Exec, discusses some leadership principles he learned while playing rugby as...
Episode 79: Managing Quarantine Remotely
01 Apr 2021
Contributed by Lukas
Uche Iloeje, Vice President medical affairs Mirdametenib at SpringWorks Therapeutics, shares his experience after he became stranded in Nigeria for fi...
Episode 78: The Digital Denouement of COVID
18 Mar 2021
Contributed by Lukas
Paul Shawah, Executive Vice President of Strategy at Veeva Systems, looks back at the past year of the pandemic to see the digital transformation of p...
Episode 77: The Effects of AI on IP
04 Mar 2021
Contributed by Lukas
Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and art...
Episode 76: Repatriating Pharma
18 Feb 2021
Contributed by Lukas
Joel Marcus, founder and executive chairman of Alexandria Real Estate Equities, and founder and CEO of Alexandria Venture Investments, discusses the d...
Episode 75: Protecting Pharma Through Cybersecurity
04 Feb 2021
Contributed by Lukas
Scott Nawrocki, managing director of digital investigations and cyber defense at Nardello & Co., discusses cybersecurity in pharma, including topi...
Episode 74: 2021 Industry Outlook
21 Jan 2021
Contributed by Lukas
Editorial Director, Lisa Henderson; European and online editor, Julian Upton; Senior Editor, Elaine Quilici ;and Assistant Editors of Pharmaceutical E...
Episode 73: Biotech’s IPO Steamroll
07 Jan 2021
Contributed by Lukas
Gregg Beloff, co-founder of Danforth Advisors, discusses the banner year biotech IPOs had in 2020, the drive behind that boom, and what the future of ...
Episode 72: Trying to Outpace Rare Disease
24 Dec 2020
Contributed by Lukas
Rich Horgan, founder and president of Cure Rare Disease(CRD), discusses how he sprang into action when his brother was diagnosed with Duchenne muscula...
Episode 71: Connecting With NPs and PAs
10 Dec 2020
Contributed by Lukas
Sacha Ward, chief client officer of Point of Care Network, discusses how COVID has affected the roles of nurse practitioners and physician assistants,...
Episode 70: Keeping Pharma Informed
26 Nov 2020
Contributed by Lukas
Krystle Buntemeyer, president of SCORR Marketing, and Bharat Mehta, co-founder of PharmaCompass, discuss a new, free online tool called Pipeline Prosp...
Episode 69: Fighting Influenza During COVID
12 Nov 2020
Contributed by Lukas
Dr. Gregg Sylvester, chief medical officer of Seqirus, discusses the importance of vaccinating against the seasonal flu amid the COVID pandemic, and h...
Episode 68: Rocking Garage Biotech
29 Oct 2020
Contributed by Lukas
Panna Sharma, CEO of Lantern Pharma, discusses garage biotech, what he’s learned from the culture, and how it might help transform certain areas of ...
Episode 67: Succeeding Through Adversity
15 Oct 2020
Contributed by Lukas
Sanjeev Luther, president and CEO of Rafael Pharmaceuticals, discusses how he managed to turn around a company on the brink of bankruptcy and advance ...
Episode 66: New Approach to Antithrombotics
01 Oct 2020
Contributed by Lukas
Dr. Neil Hayward, CEO and founder of eXlthera, is here to discuss his company, which is developing Factor XI inhibitor antithrombotics that are attack...
Episode 65: Creating a Path for Innovation
17 Sep 2020
Contributed by Lukas
George Baxter, CEO of Edinburgh Innovations, is here to discuss the company's commercialization model, and how his group is bringing innovation to mar...
Episode 64: The Complexities of Managing ADHD
03 Sep 2020
Contributed by Lukas
Jack Khattar, president and CEO of Supernus Pharmaceuticals, talks about his experience bringing ADHD drugs to market in a challenging environment.
Episode 63: Three Simple Principles to Improve Leadership
20 Aug 2020
Contributed by Lukas
Eric Turbiville, author of the recently published book “The Perfect Leadership Triad: How Top Executives Maximize Productivity through People, Coach...
Episode 62: The Future of Pharma’s Supply Chain
06 Aug 2020
Contributed by Lukas
Kurt Orlofski, CEO of Pharmaceutical Associates Inc., discusses what the pharmaceutical supply chain might look like post COVID-19, and how companies ...
Episode 61: Preparing for Virtual High-Stakes Meetings
23 Jul 2020
Contributed by Lukas
Jim and Cindy DiBiasi, co-founders of 3D Communications, talk about how to prepare for virtual high-level meetings, such as important regulatory prese...
Episode 60: Leading With Compassion
09 Jul 2020
Contributed by Lukas
Tim Walbert, CEO of Horizon Therapeutics, shares his unique perspective on managing the Chicago location of the company through COVID-19, in light of ...
Episode 59: Using Tau to Target Alzheimer’s
25 Jun 2020
Contributed by Lukas
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative disease...
Episode 58: Understanding FDA’s Gene Therapy Guidelines
11 Jun 2020
Contributed by Lukas
Dr. Jonathan Gertler, CEO of Back Bay Life Science Advisors, and Dr. Stephan Gauldie, Managing Director of Back Bay, talk about the new guidelines set...
Episode 57: Planning for Pharma’s New Normal
28 May 2020
Contributed by Lukas
Pratap Khedkar, managing principal of ZS Associates, talks about pharma’s scenario planning amid COVID-19 as it looks to settle into a new normal.
Episode 56: Killing Cancer Through Direct Injection
14 May 2020
Contributed by Lukas
Lew Bender, founder of Intensity Therapeutics and the inventor of Intensity’s DfuseRx platform technology, discusses the technology that allows the ...
Episode 55: Developing a Maternal RSV Vaccine
30 Apr 2020
Contributed by Lukas
Kathrin Jansen, Senior Vice President and Head of Vaccine Research and Development at Pfizer, talks about the challenges of creating a new maternal va...
Episode 54: Taking Advantage of Digital Marketing
15 Apr 2020
Contributed by Lukas
Chris Paquette, DeepIntent co-founder and CEO, talks about the evolution of digital marketing in pharma, specifically, how to approach data and techno...
Episode 53: Fabulous Pharma Females
02 Apr 2020
Contributed by Lukas
Barbara Ryan, founder of Barbara Ryan Advisors, a member of PharmExec’s editorial advisory board, and the founder of Fabulous Pharma Females discuss...
Episode 52: Cannabinoids
19 Mar 2020
Contributed by Lukas
Yuval Cohen, CEO of Corbus Pharmaceuticals, talks about cannabinoids, the differences between natural and synthetic products, and how biotechs and pha...
Episode 51: Combating Coronavirus
05 Mar 2020
Contributed by Lukas
Dr. Eric von Hofe, Chief Scientific Officer at NuGenerex Immuno-Oncology talks about the recent outbreak of Wuhan coronavirus around the world and how...
Episode 50: Pharma Pricing Climate in Washington
20 Feb 2020
Contributed by Lukas
Mike Strazzella, head of federal government relations for Buchanan Ingersoll & Rooney, talks about pricing issues in the pharmaceutical industry, ...
Episode 49: Navigate Emerging Markets with Data Science
06 Feb 2020
Contributed by Lukas
Pharm Exec speaks with Nigel Breakwell and Ben Randal, co-founders of Dot I/O Health. Nigel and Ben talk about how they’re using data science in the...
Episode 48: 2020 Industry Outlook
23 Jan 2020
Contributed by Lukas
Pharm Exec editors discuss the themes chosen for the January issue focusing on industry trends for the coming year.
Episode 47: Identifying Adherence Issues
09 Jan 2020
Contributed by Lukas
Heather Monte, Director of Operations for DirectRx, talks about the specialty pharma’s new Patient Scorecard, which aims to identify and improve adh...
Episode 46: Persistence and Planning Pays Off
19 Dec 2019
Contributed by Lukas
Julia Owens, co-founder and CEO of Millendo Therapeutics talks about how to keep a company on the path to success, even when there are bumps in the ro...
Episode 45: Getting Drug Approval Through FDA LPAD
05 Dec 2019
Contributed by Lukas
William Lewis, chairman and CEO of Insmed talks about the approval of the company’s drug Arikayce through the FDA’s Limited Population Pathway for...